United States next-generation
biomanufacturing market is anticipated to witness significant growth during the
forecast period owing to thriving
biopharmaceutical sector and increasing funds being provided by government for
the development of innovative biomanufacturing technologies.
The addition of new products in the development pipeline and entry of more
companies in next-generation biomanufacturing are further acting as key growth
factors for United States next-generation biomanufacturing market.
Additionally, the market is focusing on the implementation of single-use
products including single-use bio-containers and single-use bioreactors, which
is further fueling the market. Also, the advantages of next-generation
biomanufacturing such as adoption of cost savings facilities and reduced risk
of contamination of products is expected to further drive the market growth
through 2027.
Moreover, the outbreak of COVID-19 has
pushed biomanufacturing industries to develop vaccines, hence, with development
of advanced vaccines, next-generation biomanufacturing market is expected to
grow significantly in United States. In addition to this, growing awareness
regarding the benefits next-generation biomanufacturing and presence of leading
manufacturers is making United States a favorable market for next-generation
biomanufacturing.
United States next-generation
biomanufacturing market is categorized based on type, medical application, end
users and region. Based on medical application, the market
can be segmented into monoclonal antibodies, hormones, vaccines, recombinant
proteins and others. Among them, the monoclonal antibodies segment is anticipated
to witness high growth through 2027 due to high rate of products approval and occurrence
of coronavirus which has led to extensive development of vaccines.
Based on end users, the United
States next-generation biomanufacturing market can be segmented into
biopharmaceutical companies, CMOs/CDMOs and research institutions. Among them,
biopharmaceutical companies are expected to contribute to major share of
revenue the United States next-generation biomanufacturing market during the
forecast period owing to higher number of biopharmaceutical companies and increasing
adoption of advanced healthcare technologies.
Major players operating in the United
States next-generation biomanufacturing market include Thermo Fisher
Scientific, Inc., Danaher Corporation, Merck & Co., Inc., Eppendorf, Inc.,
Sartorius Corporation, GEA North America, Inc., PBS Biotech, Inc, Applikon
Biotechnology, Inc. and Meissner Filtration Products, Inc., among others. The
market players are undergoing growth strategies like strategic partnerships and
strategic collaborations & partnerships.
Objective of the Study:
- To analyze and estimate the market size of United
States next-generation biomanufacturing market from 2017 to 2020.
- To estimate and forecast the market size of United
States next-generation biomanufacturing market from 2021 to 2027 and
growth rate until 2027.
- to classify and forecast United States next-generation
biomanufacturing market based on type,
medical application, end users, company and regional distribution.
- To identify dominant region or segment in the United
States next-generation biomanufacturing market.
- To identify drivers and challenges for United
States next-generation biomanufacturing market.
- To examine competitive developments such as
expansions, mergers & acquisitions, etc., in United States next-generation
biomanufacturing market.
- To conduct pricing analysis for United States next-generation
biomanufacturing market.
- To identify and analyze the profile of leading
players operating in United States next-generation biomanufacturing market.
- To identify key sustainable strategies adopted
by market players in United States next-generation biomanufacturing market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of next-generation biomanufacturing companies across United
States. Subsequently, TechSci Research conducted primary research surveys with
the identified companies. While interviewing, the respondents were also
enquired about their competitors. Through this technique, TechSci Research
could include the companies who could not be identified due to the limitations
of secondary research. TechSci Research analyzed the presence of all major
players across the countries.
TechSci Research calculated the market size of United States next-generation
biomanufacturing market using a bottom-up approach, wherein data for various
end-user segments was recorded and forecast for the future years. TechSci
Research sourced these values from the industry experts and company
representatives and externally validated through analyzing historical data of
these services and end users for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press
releases, company annual reports, investor presentations and financial reports
were also studied by TechSci Research.
Key Target Audience:
- Next-generation biomanufacturing
manufactures, suppliers, distributors and other stakeholders
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to next-generation biomanufacturing
- Market research and
consulting firms
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as next-generation biomanufacturing manufacturers, suppliers, partners,
end users, etc., besides allowing them in strategizing investments and
capitalizing on market opportunities.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Years
|
2017 – 2020
|
|
Estimated Year
|
2022E
|
|
Forecast Period
|
2023F – 2027F
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F
|
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
·
Type
·
Medical Application
·
End User
|
|
Region Scope
|
South-Region, West-Region, Mid-West Region & Northeast-Region
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Inc., Danaher Corporation, Merck
& Co., Inc., Eppendorf, Inc., Sartorius Corporation, GEA North America,
Inc., PBS Biotech, Inc, Applikon Biotechnology, Inc. and Meissner Filtration
Products, Inc
|
|
Customization Scope
|
10% free report customization with purchase. Addition or
alteration to regional & segment scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase
options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, United States next-generation
biomanufacturing market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
- United States Next-Generation Biomanufacturing Market,
By Type:
- Continuous Upstream Biomanufacturing
- Single-Use Upstream Biomanufacturing
- Downstream Biomanufacturing
- United States Next-Generation Biomanufacturing
Market, By Medical Application:
- Monoclonal Antibodies
- Hormones
- Vaccines
- Recombinant Proteins
- Others
- United States Next-Generation Biomanufacturing
Market, By End Users:
- Biopharmaceutical Companies
- CMOs/CDMOs
- Research Institutions
- United States Next-Generation Biomanufacturing Market,
By Region:
- North-East
- Mid-West
- West
- South
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States next-generation biomanufacturing market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Profit Margin Analysis
- Profit margin analysis
in case of direct and indirect sales channel.
It is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]